Brief: G1 Therapeutics Provides Corporate Update
Jan 8 (Reuters) - G1 Therapeutics Inc GTHX.O :
* G1 THERAPEUTICS PROVIDES CORPORATE UPDATE AT THE 42ND
ANNUAL
J.P. MORGAN HEALTHCARE CONFERENCE
* G1 THERAPEUTICS INC - CASH RUNWAY EXPECTED INTO 2025
* G1 THERAPEUTICS- INITIAL DATA FROM PHASE 2 TRIAL IN
COMBINATION
WITH ADC SG SUGGEST POTENTIAL MEANINGFUL IMPROVEMENT IN OS FOR
PATIENTS GETTING TRILACICLIB
Source text for Eikon: ID:nGNX8pYyNp
Further company coverage: GTHX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify